Published online Aug 6, 2021. doi: 10.12998/wjcc.v9.i22.6244
Peer-review started: January 12, 2021
First decision: April 29, 2021
Revised: May 7, 2021
Accepted: June 3, 2021
Article in press: June 3, 2021
Published online: August 6, 2021
Processing time: 196 Days and 14.9 Hours
The incidence rate of intussusception in Henoch-Schönlein purpura (HSP) is about 5%. It is the most common surgical acute abdomen in children with HSP. However, few reports have assessed the etiology of intussusception in children with HSP due to low clinical incidence. In particular, the risk factors for intussusception in children with HSP are largely unknown.
The aim of this study was to identify risk factors for the development of intussusception in children with HSP and gastrointestinal (GI) involvement.
The aim of this study was to identify risk factors for the development of intussusception in children with HSP and GI involvement.
Sixty children with HSP and intussusception who were hospitalized at Beijing Children's Hospital Affiliated to Capital Medical University from January 2006 to December 2018 were selected. One hundred cases of abdominal HSP without intussusception at Beijing Children's Hospital during the same period were randomly selected as a control group. The general clinical data of all HSP patients were investigated, including gender, age of onset, onset time, clinical symptoms and signs, laboratory examination, imaging manifestations, treatment measures, etc. Univariate and multiple logistic regression analyses were performed to identify possible risk factors.
The 60 children in the intussusception group included 27 girls (45%) and 33 boys (55%), while 100 children in the non-intussusception group included 62 girls (62%) and 38 boys (38%). The median age was 6 years and 5 mo. Univariate and multivariate regression analyses showed that age of onset, failure to receive glucocorticoid treatment within 72 h after GI symptoms, hematochezia, and D-dimer levels were independent risk factors for intussusception in children with HSP (P < 0.05).
Age at onset below 6 years, not receiving glucocorticoid therapy within 72 h of onset of GI symptoms, hematochezia, and increased D-dimer levels are independent risk factors for intussusception in children with HSP with GI involvement. Caution is needed in children suffering from HSP with GI involvement and showing at least one of the abovementioned factors, to avoid further disease aggravation and intussusception.
In view of the above factors, it is necessary to conduct a large sample multicenter study.